R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The pharma trends leading to higher demand for CDMOs

Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations.

R&D

LNPs: The unknown enabler behind mRNA vaccines

Drug delivery technologies are crucial to allow drugs to reach their full potential, and yet they rarely receive much spotlight.

R&D

Insulin costs & pharma manufacturing

While the pharma press often focuses on R&D and drug development, the actual manufacture of drugs is an interesting space in its own right that drives many of the trends in drug pricing

R&D

New strategies to manage clinical trial risk

It is essential for healthcare and pharmaceutical companies to be aware of both critical and non-critical risks when conducting quality clinical trials.

R&D